Royal Bank Of Canada Green Light Biosciences Holdings, Pbc Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.18 - $0.48 $880 - $2,349	-4,894 Reduced 81.87%	1,084 $0
Q1 2023 May 15, 2023	SELL	$0.34 - $1.19 $3,026 - $10,592	-8,901 Reduced 59.82%	5,978 $2,000
Q4 2022 Feb 14, 2023	BUY	$1.03 - $2.0 $12,154 - $23,600	11,800 Added 383.24%	14,879 $17,000
Q3 2022 Nov 14, 2022	BUY	$0.42 - $3.92 $1,260 - $11,763	3,001 Added 3847.44%	3,079 $7,000
Q2 2022 Aug 15, 2022	SELL	N/A	-1,995 Reduced 96.24%	78 $0
Q1 2022 May 16, 2022	BUY	N/A	2,073 New	2,073 $20,000

51.5K

Ticker GRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 151,460,000
Description
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.